2219 York Road, Suite 102, Lutherville-Timonium, MD 21093
(410) 469-7111

Corneal Cross Linking (CXL) for Keratoconus

Revolutionizing Keratoconus Treatment: Corneal Cross-Linking (CXL)

Discover the power of Corneal Cross-Linking (CXL), a groundbreaking procedure designed to fortify your cornea and halt the progression of Keratoconus and other corneal diseases. This minimally invasive treatment utilizes liquid riboflavin and precision-controlled ultraviolet light to effectively stabilize corneal changes, providing a new lease on life for your eyes.

CXL is widely recognized globally as a pivotal treatment for Keratoconus, offering hope to those in the early stages of the condition. By opting for CXL, you take a proactive step towards preserving your vision and preventing further deterioration.

FDA Endorsement: A Milestone in Eye Care

As of April 18, 2016, the FDA has officially approved Photrexa for Corneal Crosslinking in Keratoconus, marking a significant advancement in the availability and recognition of this essential treatment.

Beyond Cross-Linking: Comprehensive Vision Solutions

While CXL is a critical intervention for early Keratoconus, it’s important to note that it does not reverse existing damage. Post-procedure, many patients find enhanced vision clarity with solutions like RGP Lenses, Scleral Lenses, PVR PROSE Treatment, or EyePrint Pro. Our team at [Your Practice Name] is dedicated to guiding you through these options to find the perfect fit for your unique eyes.

Is Corneal Cross-Linking Right for You?

Embark on a journey to better vision with Corneal Cross-Linking. If you’re experiencing the early stages of Keratoconus or notice constant changes in your cornea, CXL might be the key to safeguarding your sight. Explore more about this transformative treatment and discover if CXL is your path to clearer, more stable vision.